Free shipping over $200 Xpresspost 1–2 business days Orders before 5 pm ET ship the same day

Eloralintide (LY3841136) – 10mg

$300.00

  • This product is intended for laboratory research use only.

  • Not for human or veterinary use.

  • Not approved for diagnostic, therapeutic, or medical applications.

  • Handle using appropriate laboratory safety procedures and personal protective equipment.

Xpresspost Shipping — Orders before 5 pm eastern standard time ship the same business day. Most Canadian addresses deliver in 1–2 business days.

Lab Results in Progress...

SKU: GLP 2 (Tirzepatide) — 65mg-1 Categories: ,

Description

Eloralintide (LY3841136) is a long-acting synthetic amylin analog studied as a selective amylin receptor agonist. The peptide is conjugated to a C20 fatty diacid moiety enabling reversible albumin binding and an extended plasma half-life consistent with once-weekly subcutaneous administration. In published preclinical work, eloralintide preferentially activates the human amylin 1 receptor (AMY1R), with reported selectivity of approximately 12-fold over the calcitonin receptor (CTR) and 11-fold over AMY3R — a profile differentiating it from non-selective amylin analogs such as cagrilintide. Eloralintide is investigated in research models for receptor pharmacology, food intake regulation, body composition, and gastrointestinal tolerability endpoints.

Benefits (Research Focus)

  • Studied as a selective AMY1R agonist with reduced calcitonin receptor activity
  • Investigated for cAMP signaling and amylin receptor pharmacology
  • Explored for food intake reduction and satiety pathway research
  • Examined for body composition endpoints (fat-mass vs lean-mass change)
  • Researched for conditioned-taste-avoidance and GI tolerability profiles

What Researchers Look At

  • Receptor binding affinity and selectivity across AMY1R / AMY3R / CTR
  • cAMP activation curves in cell lines expressing amylin receptor subtypes
  • Food intake, body weight, and adipose-tissue change in DIO rodent models
  • Pharmacokinetics and albumin-binding driven half-life extension
  • Comparative endpoints versus cagrilintide and pramlintide

Quick Specs

  • Form: Lyophilized white powder
  • Net Peptide Content: 10 mg per vial
  • Quantity: 1 vial
  • Purity: ≥99% by HPLC
  • Appearance: White to off-white lyophilizate
  • Reconstitution: Bacteriostatic or sterile water (added by the end researcher)
  • Storage (lyophilized): Protect from light
  • Storage (reconstituted): Store at 2–8 °C; for short-term laboratory use only

Identity Basics

  • Compound: Eloralintide
  • Synonyms: LY3841136; LY-3841136; AMY1176
  • Class: Selective amylin receptor agonist (AMY1R-preferring); long-acting amylin analog
  • Modification: Lipidated with C20 fatty diacid via γGlu-γGlu linker on a Lys residue; intramolecular methylene bridge between Cys2–Cys7
  • Chemical Formula: C201H319N49O65S2
  • Molecular Weight: 4526.10 g/mol
  • CAS: 2883634-40-8

Disclaimer

  • This product is intended for laboratory research use only.
  • Not for human or veterinary use.
  • Not approved for diagnostic, therapeutic, or medical applications.
  • Handle using appropriate laboratory safety procedures and personal protective equipment.

Additional information

Weight .006 g
Dimensions 1.7 × 1.7 × 3.8 in
Dose (mg)

10 mg

Pack Size

10-Pack, Single Vial